4//SEC Filing
Furiex Pharmaceuticals, Inc. 4
Accession 0001437749-13-008386
CIK 0001484478operating
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 5:47 PM ET
Size
13.9 KB
Accession
0001437749-13-008386
Insider Transaction Report
Form 4
CORR PETER B
Director
Transactions
- Gift
Common Stock
2013-06-28−2,913→ 3,595 total - Sale
Common Stock
2013-06-28$34.03/sh−385$13,102→ 6,508 total - Gift
Common Stock
2013-07-01−15→ 3,580 total
Holdings
- 8,675
Stock Options (to buy)
Exercise: $13.94Exp: 2021-05-19→ Common Stock (8,675 underlying) - 17,500
Stock Options (to buy)
Exercise: $18.22Exp: 2022-05-24→ Common Stock (17,500 underlying) - 8,825
Stock Options (to buy)
Exercise: $13.45Exp: 2021-10-12→ Common Stock (8,825 underlying) - 12,970
Stock Options (to buy)
Exercise: $9.11Exp: 2020-06-17→ Common Stock (12,970 underlying)
Footnotes (6)
- [F1]Represents shares sold to pay the exercise price of stock options exercised in order to make a charitable donation.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.99 to $34.17, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The options were awarded on 6/17/2010 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F4]The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F5]The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- [F6]The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
Documents
Issuer
Furiex Pharmaceuticals, Inc.
CIK 0001484478
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001484478
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 5:47 PM ET
- Size
- 13.9 KB